SCHEMBL7374802

SCHEMBL7374802

NC(=O)c1nncc2c1ccc1ccccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ILK Q13418 1/20 0.42
LCK P06239 1/20 0.41
MAP2K3 P46734 1/20 0.41
MAP2K6 P52564 1/20 0.41
BTK Q06187 1/20 0.41
MAP3K19 Q56UN5 1/20 0.41
NEK10 Q6ZWH5 1/20 0.41
HPRT1 P00492 2/20 0.41
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
HPGD P15428 2/20 0.39
TDP1 Q9NUW8 3/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
CYP2A6 P11509 1/20 0.39
KDM4E B2RXH2 4/20 0.38
GAA P10253 1/20 0.38
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CCNA1 P78396 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9738820 0.83 ALDH1A1 (0.49) ILKLCKMAP2K3MAP2K6BTK
SCHEMBL29617978 0.83 ALDH1A1 (0.49) ILKLCKMAP2K3MAP2K6BTK
SCHEMBL24183836 0.70 HPRT1 (0.48) HPRT1ALDH1A1MAPTHPGDTDP1
Phenanthrene SCHEMBL27765703 0.70 HSD17B10 (0.63) HPRT1ALDH1A1MAPTHPGDTDP1
SCHEMBL260660 0.69 KDM4E (0.53) ALDH1A1MAPTTDP1KDM4EGAA
SCHEMBL27853755 0.69 KDM4E (0.41) LCKMAP2K3MAP2K6BTKMAP3K19
SCHEMBL9983864 0.69 PIM3 (0.47) LCKMAP2K3MAP2K6BTKMAP3K19
SCHEMBL28279288 0.68 MAP2K3 (0.53) LCKMAP2K3MAP2K6BTKMAP3K19
SCHEMBL27682494 0.68 MAP2K3 (0.53) ILKLCKMAP2K3MAP2K6BTK
SCHEMBL14993997 0.68 ALDH1A1 (0.47) ALDH1A1MAPTHPGDTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1021415-A1 TRICYCLIC AMINOALKYLCARBOXAMIDES; NOVEL DOPAMINE D 3? RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-07-26 EP disclosed
US-5910586-A Tricyclic aminoalkylcarboxamides; dopamine D3 receptor subtype specific ligands NEUROGEN CORPORATION (US) 1999-06-08 US disclosed
US-5688950-A NERVOUS SYSTEM DISORDERS, SIDE EFFECT REDUCTION NEUROGEN CORPORATION (US) 1997-11-18 US disclosed
WO-1997040015-A1 TRICYCLIC AMINOALKYLCARBOXAMIDES; NOVEL DOPAMINE D3 RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 1997-10-30 WO disclosed